发明公开
EP1039912A1 ANGIOSTATIC AGENTS AND COMPOSITIONS FOR CONTROLLING OCULAR HYPERTENSION
有权
血管生成抑制化合物和监测组合物中,升高的眼内压力操纵
- 专利标题: ANGIOSTATIC AGENTS AND COMPOSITIONS FOR CONTROLLING OCULAR HYPERTENSION
- 专利标题(中): 血管生成抑制化合物和监测组合物中,升高的眼内压力操纵
-
申请号: EP98961956.4申请日: 1998-12-07
-
公开(公告)号: EP1039912A1公开(公告)日: 2000-10-04
- 发明人: CLARK, Abbot, F.
- 申请人: ALCON LABORATORIES, INC.
- 申请人地址: 6201 South Freeway Fort WorthTexas 76134-2099 US
- 专利权人: ALCON LABORATORIES, INC.
- 当前专利权人: ALCON LABORATORIES, INC.
- 当前专利权人地址: 6201 South Freeway Fort WorthTexas 76134-2099 US
- 代理机构: Best, Michael, Dr.
- 优先权: US994114 19971219
- 国际公布: WO9932127 19990701
- 主分类号: A61K31/57
- IPC分类号: A61K31/57 ; A61K31/575 ; A61K31/56
摘要:
Compositions of angiostatic agents for treating GLC1A glaucoma and methods for their use are disclosed.
公开/授权文献
信息查询